Ajaykumar Singh

2PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Feb 23, 2026
Sustained Complete Response to Brigatinib in a Young Patient With ALK-Positive NSCLC Harboring I1171N Mutation Post-Alectinib Resistance.

Akhil Kapoor, Ajay Kumar Singh, Mahesh Chaudhary

|Dec 31, 2025
Safety and Efficacy of Alectinib in the First Line for ALK-Mutated Lung Cancer: A Real-World Data from India.

Ajaykumar Singh, Vanita Noronha, Vijay Patil

Pageof 1

Frequent Collaborators

2 joint publications

Akhil Kapoor

1 joint publications

Mahesh Chaudhary

1 joint publications

Anuj Gupta

1 joint publications

Bipinesh Sansar